| 000 | 01100nam a2200301 i 4500 | ||
|---|---|---|---|
| 999 |
_c12682 _d12682 |
||
| 001 | 19689135 | ||
| 005 | 20210301101151.0 | ||
| 008 | 890510s1989 paua b 00110 eng d | ||
| 010 | _a89090760 | ||
| 020 | _a0912734205 | ||
| 040 |
_aUCW _cUCW _dMXC _erda |
||
| 082 | 0 | 4 |
_222 _a615.7 _bA.H.D |
| 100 | 1 | 0 |
_aAbdou, Hamed M. _q(Hamed Mahmmoud), _d1941-, _eauthor. |
| 245 | 1 | 0 |
_aDissolution, bioavailability & bioequivalence / _cHamed M. Abdou (Vice President, Pharmaceutical Thchnical operations, E.R squibb and sons, Inc. and visiting Professor, College of pharmacy, Rutgers University) |
| 264 | 1 |
_aEaston, Penn. : _bMack, _c1989 |
|
| 264 | 4 | _c©1989 | |
| 300 |
_axvii, 554 pages : _billustrations (black and withe) ; _c27 cm |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 504 | _aIncludes bibliographical references and index | ||
| 650 | 0 |
_aDrugs _xTherapeutic equivalency |
|
| 650 | 0 |
_aDrugs _xBioavailability |
|
| 650 | 2 | _aBiological Availability | |
| 650 | 2 | _aTherapeutic Equivalency | |
| 942 |
_2ddc _cBK |
||